New Mission, New Website coming soon! Learn more now.

Equities logo
Search
Close this search box.

Equillium’s $70 Million IPO Expected This Week for Immuno-Inflammatory Diseases

Lead candidate targeting graft-versus-host disease (GvHD) (Image: Equillium).